Posian Pharma Private Limited
About Posian Pharma Private Limited
Data last updated:
Posian Pharma Private Limited is a private limited company based in Khurda, Odisha, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 03 March 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24232OR2010PTC011689. Its GSTIN is 21AAFCP3898R1ZN (Odisha).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Samir Kumar Paikaray and Shubhrajyoti Panda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Konark Nagar Po – Pallahat, Khurda, Odisha, India – 752056.
As per the financials filed for FY 2023, the company reported a revenue of ₹30.34 Lakh, a decline of 66% compared to the previous year. For the same year it recorded a net loss of ₹7.43 Lakh (net margin -24.5%) and EBITDA of -₹2.07 Lakh (EBITDA margin -6.8%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 16% over five years.
Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Posian Pharma Private Limited's registered office is in Khurda, Odisha. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKonark Nagar Po – Pallahat, Khurda, Odisha, India – 752056
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Posian Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Posian Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Posian Pharma Private Limited, buy the company report.
Financials of Posian Pharma Private Limited
FY 2025 filings availablePosian Pharma Private Limited reported revenue of ₹30.34 Lakh (down 66% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 66% fall in the latest year. EBITDA fell 191% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7.43 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.8% | ||||
| Net Profit Margin | -24.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Posian Pharma Private Limited, buy the company report.
Board of directors of Posian Pharma Private Limited
Posian Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samir Kumar Paikaray | Director | 30 Dec 2014 | 11 Years 10 Months | Current |
| Shubhrajyoti Panda | Director | 27 Sep 2025 | 1 Years 1 Months | Current |
| Nalini Kanta Panda | Director | 27 Sep 2025 | 1 Years 1 Months | Current |
Peer comparison
Posian Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Blumerq Healthcare Private Limited | ₹30.37 Lakh (FY 2022) | Chennai, Tamil Nadu, India | ||||
| Rungta Holdings Private Limited | ₹30.36 Lakh (FY 2025) | 27.0% | Kolkata, West Bengal, India | |||
| Jaimisha Unity Sales Private Limited | ₹30.36 Lakh (FY 2022) | -79.0% | Dombivli East, Maharashtra, India | |||
| Alillys Pharma (OPC) Private Limited | ₹30.36 Lakh (FY 2025) | 46.0% | Sikar, Rajasthan, India | |||
| Scic Tradex India Private Limited | ₹30.35 Lakh (FY 2025) | 12.0% | Delhi, India | |||
| Posian Pharma Private Limitedthis company | ₹30.34 Lakh (FY 2023) | -₹7.43 Lakh | -24.5% | -66.0% | Khurda, Odisha, India | |
| Mishica Global Private Limited | ₹30.34 Lakh (FY 2021) | -63.0% | New Delhi, Delhi, India | |||
| Sraw Products Private Limited | ₹30.32 Lakh (FY 2025) | -16.0% | Gaya, Bihar, India | |||
| Lalantop Consumer Private Limited | ₹30.32 Lakh (FY 2019) | 168.0% | Delhi, India | |||
| Raavitto International Private Limited | ₹30.32 Lakh (FY 2021) | -86.0% | Kozhikode, Kerala, India | |||
| Asthev Healthcare Private Limited | ₹30.32 Lakh (FY 2025) | 40.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Posian Pharma Private Limited, buy the company report.
Auditor
Posian Pharma Private Limited is audited by SOURJYA & BISWAJIT CHARTERED ACCOUNTANTS for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SOURJYA & BISWAJIT CHARTERED ACCOUNTANTS | FY 2017 | 322779E |
Shareholding
The shareholding of Posian Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Posian Pharma Private Limited, buy the company report.
Legal cases
Posian Pharma Private Limited has 1 court case on record: 1 filed by Posian Pharma. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Khurda, Orissa | Court case (I.c.c) | Filed by the company against Priyanka Pharmaceuticals Represented by Its Proprietor Prasanta Kumar Paltasingh | Pending |
To see the full case history of Posian Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Posian Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Posian Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAFCP3898R1ZN | Odisha | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Posian Pharma Private Limited, buy the company report.
Recent activity
Posian Pharma Private Limited has 7 board changes on record since 2010: 5 appointments and 2 cessations. The latest: Nalini Kanta Panda was appointed as Director on 27 Sep 2025.
Frequently asked questions
Posian Pharma is an active private limited company based in Khurda, Odisha, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 03 March 2010 (16+ years old) and is registered under CIN U24232OR2010PTC011689.
Posian Pharma has 3 current directors:
- Samir Kumar Paikaray - Director
- Shubhrajyoti Panda - Director
- Nalini Kanta Panda - Director
The latest financial statements of Posian Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Posian Pharma is 21AAFCP3898R1ZN, registered in Odisha.
The CIN (Corporate Identification Number) of Posian Pharma is U24232OR2010PTC011689. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Posian Pharma has 1 court case on record: 1 filed by the company. 1 is pending.
Posian Pharma was incorporated on 03 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Posian Pharma by revenue are Blumerq Healthcare Private Limited, Rungta Holdings Private Limited, Jaimisha Unity Sales Private Limited, Alillys Pharma (OPC) Private Limited, Scic Tradex India Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Nalini Kanta Panda was appointed as Director on 27 Sep 2025. Shubhrajyoti Panda was appointed as Director on 27 Sep 2025. Pravat Kumar Dash ceased to be Director on 30 Dec 2014. Posian Pharma has 7 board changes on record in total.
The registered office of Posian Pharma is at Konark Nagar Po – Pallahat, Khurda, Odisha, India – 752056.
Posian Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
